Latest Health News

Emyria has cleared a key operational hurdle by resolving Authorised Prescriber capacity constraints in Perth and Queensland, enabling a planned expansion of treatment days in Q4 2026 through the recruitment of 15 new therapists.

Servcorp Limited delivered a record FY26 with a 24% rise in underlying NPBIT to $87 million, boosted dividends by 14%, and outlined a cautious yet optimistic FY27 growth strategy.

Medical Developments International (ASX:MVP) reported a 9% revenue increase to $42.6 million and a 566% jump in net profit to $0.6 million for FY26, driven by robust growth in its Pain Management segment and expanded paediatric approvals in Europe.

Memphasys has cleared a key regulatory hurdle in Vietnam for its Felix™ System, prompting a significant first commercial cartridge order and marking early clinical success in a fast-growing fertility market.

Redox Limited reported a robust FY26 with profit after tax rising 19.2% to $91.9 million on record revenue of $1.33 billion, supported by strong North American growth and improved margins. The company declared a fully franked final dividend of 6.5 cents, bringing total dividends to 13 cents per share.

Lindian Resources confirms Kangankunde Rare Earths Project remains on track for first production in late 2026, with concurrent progress across construction, mining, and operational readiness. The company is expanding its operational footprint internationally and strengthening its team to support the transition from construction to production.

Bega Cheese Limited has delivered a robust FY2026 with a $54.8 million statutory profit, a 6.7% revenue increase, and a raised final dividend of 7.5 cents per share. The company is advancing its strategic growth plans focused on high-protein products, international expansion, and sustainability initiatives.

Emeco Holdings posted a 5% rise in operating NPAT for FY26, strengthened its balance sheet with net debt down to $127 million, and launched a 10% on-market share buy-back while advancing its net zero emissions strategy.

Medibank Private Limited reported a 27.5% jump in net profit after tax to $638.7 million for FY26, driven by steady health insurance growth and a 31.3% surge in its Medibank Health segment. The company declared a fully franked final dividend of 10.9 cents per share and updated its Net Zero emissions strategy.

Cleanaway Waste Management reported a 13.5% revenue increase and 14.2% underlying EBIT growth in FY26 despite a statutory profit drop, advancing its Blueprint 2030 2.0 strategy and facing a $9.4 billion takeover bid.

BLIS Technologies has kicked off FY27 with a 42% revenue increase and a return to EBITDA profitability, driven by strong B2B growth in Asia Pacific and China.

Percheron Therapeutics reduced its FY2026 loss to $4.79 million as it prepares to launch a pivotal phase II trial for its immuno-oncology drug HMBD-002, while managing a CEO transition and tightening cash reserves.